Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches

European Journal of Pediatrics

Volumn 172, Issue 12, 2013, Pages 1679-1685

  Carnovale, Carla ^a   Conti, Valentino ^b   Perrone, Valentina ^a   Antoniazzi, Stefania ^a   Pozzi, Marco ^c   Merlino, Luca ^d   Venegoni, Mauro ^b   Clementi, Emilio ^a,c   Radice, Sonia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Regional Centre for Pharmacovigilance   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d Operative Unit of Territorial Health Services   (Italy)

Author keywords

Adverse drug reaction; Off label use; Paediatric; Prescription

Indexed keywords

AMITRIPTYLINE; ATENOLOL; AZITHROMYCIN; CETIRIZINE; CITALOPRAM; CLARITHROMYCIN; DESLORATADINE; ESOMEPRAZOLE; FLUNISOLIDE; ITRACONAZOLE; KETOPROFEN; LANSOPRAZOLE; LEVOFLOXACIN; OMEPRAZOLE; OXATOMIDE; PROPRANOLOL; PRULIFLOXACIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; CHILD; HUMAN; INAPPROPRIATE PRESCRIBING; INFANT; ITALY; MAJOR CLINICAL STUDY; NEWBORN; OFF LABEL DRUG USE; OUTPATIENT CARE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC THERAPY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUOROQUINOLONES; HUMANS; INAPPROPRIATE PRESCRIBING; INFANT; INFANT, NEWBORN; ITALY; MALE; OFF-LABEL USE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES;

EID: 84890425951     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2111-7     Document Type: Article

References (29)

1. Art. 3 D. Lgs. 17 febbraio 1998, n.23, convertito, con modificazioni nella Legge 8 aprile 1998, n.94.1
2. Bradley JS, Jackson MA (2011) The use of systemic and topical fluoroquinolones. Pediatrics 128(4):1034-1045
3. Bücheler R, Schwab M, Mörike K, Kalchthaler B, Mohr H, Schröder H, Schwoerer P, Gleiter CH (2002) Off-label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 324:1311-1312
4. Choonara I (2007) Regulation of drugs for children in Europe. BMJ 335:1221-1222
5. Choonara I (2013) Educational paper: aspects of clinical pharmacology in children - pharmacovigilance and safety. Eur J Pediatr 172:577-580
6. Cizman M (2003) The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21(4):297-307
7. Clavenna A, Bonati M (2009) Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol 65(8):749-755
8. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van den Anker J (2000) Survey of unlicensed and off-label drug use in paediatric wards in European countries. European network for drug investigation in children. BMJ 320:79-82
9. Etminan M, Forooghian F, Brophy JM, Bird ST, Maberley D (2012) Oral fluoroquinolones and the risk of retinal detachment. JAMA 307(13):1414-1419
10. European commission. European commission, Regulation (EC) no 19012006 of the European Parlament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768 92, Directive 2001 20 EC, Directive 200183EC and Regulation (EC) No 7262004. Official J 2006; L378:1-19. http://ec.europa.eu/health/files/eudralex/vol-1/reg-2006-1901/reg- 2006-1901-en.pdf. Accessed 16 Jan 2008
11. European Medicines Agency (London 2006) Assessment of the paediatric needs cardiovascular products. Doc. Ref.: EMEA/439649/2006. http://www.emea. europa.eu/pdfs/human/peg/43964906en.pdf. 2 Nov 2007
12. European Medicines Agency. Priority list of off-patent medicinal products for pediatric studies London: EMEA, 2012 (EMEA/98717/2012)
13. Guidelines for ATC Classification and DDD Assignment 2011. Oslo, Norway, WHO Collaborating Centre for Drug Statistics Methodology, 2010
14. Harrison JN, Cluxton-Keller F, Gross D (2012) Antipsychotic medication prescribing trends in children and adolescents. J Pediatr Health Care 26(2):139-145
15. Hoppu K (2007) Paediatric clinical pharmacology: at the beginning of a new era. Eur J Clin Pharmacol 64(2):201-205
16. Kimland E, Odlind V (2012) Off-label drug use in pediatric patients. Clin Pharmacol Ther 91(5):796-801
17. Morales-Carpi C, Estañ L, Rubio E, Lurbe E, Morales-Olivas FJ (2010) Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol 66:315-320
18. Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, Brune K, Hinz B (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27:1059-1067
19. Pandolfini C, Bonati M (2004) A literature review on off-label drug use in children. Eur J Pediatr 164:552-558
20. Polachek H, Leibovitz E, Dagan R (2011) Joint cartilage lesions caused by quinolones in young animals - can we generalize to children? Harefuah 150(9):721-724
21. Rossignoli A, Clavenna A, Bonati M (2007) Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol 63:1099-1106
22. Schirm E, Tobi H, Jong-van D, den Berg LT (2003) Risk factors for unlicensed and off-label drug use in children outside the hospital. Pediatrics 111:291-295
23. Stahlmann R, Lode HM (2013) Risks associated with the therapeutic use of fluoroquinolones. Expert Opin Drug Saf 12:497-505
24. Stam J, van Stuijvenberg M, Grüber C, Mosca F, Arslanoglu S, Chirico G, Braegger CP, Riedler J, Boehm G, Sauer PJ (2012) Antibiotic use in infants in the first year of life in five European countries. Acta Pædiatrica 101(9):929-934
25. Sturkenboom MC, Felisi M, Manfredi C, Neubert A, Cantarutti L, Padula R, Sen F, Verhamme K (2009) Paediatric status and off-label use of drugs in children in Italy, United Kingdom and the Netherlands. Pharmaceuticals Policy Law 11(1):51-59
26. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC (2008) Drug use in children: cohort study in three European countries. BMJ 337:a2245
27. Sukkar E (2012) European researchers are urged to do more trials in children, conference hears. BMJ 344:2350
28. Tuleu C, Breitkreutz J (2013) Educational paper: formulation-related issues in pediatric clinical pharmacology. Eur J Pediatr 172:717-720
29. Working Group Pediatrico dell'AIFA. La prima lista dei farmaci cardiovascolari autorizzati per un uso pediatrico